12:00 AM
Apr 19, 2010
 |  BC Week In Review  |  Company News  |  Deals

Arecor, Genzyme deal

The companies will collaborate to develop stable formulations of labile biologics from Genzyme's pipeline using Arecor's Arestat technology....

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >